The drug was 88% effective against the need for medical attention among those in their second respiratory virus season.

Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

UK health officials say the increase is largely due to an uptick in antibiotic-resistant Escherichia coli infections.

Some Alberta doctors are calling on the provincial government to make an injection designed to protect newborns from severe ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

The good news: In October, a new preventive medicine, the monoclonal antibody Nirsevimab, became available to babies and at-risk toddlers to help protect them from RSV (Respiratory Syncytial Virus).

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically ...

Infants will be able to receive a free immunisation to protect them against serious illness from respiratory syncytial virus (RSV), under a new $16.6 million NSW Government RSV prevention program to ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

Do they not have enough to go around?” Pneumonia, bronchiolitis, asthma, and potential mortality are complications of RSV ...